Two recent studies have reported an association between antenatal exposure to co-amoxyclav, either alone or in combination with erythromycin, and neonatal necrotising enterocolitis (NEC).^1,2 Based on the analyses of secondary outcomes in these studies, the authors raised concerns about the use of co-amoxyclav antenatally and recommended further investigation of its use in the neonatal …